TCM
TMDX icon

Triumph Capital Management’s Transmedics TMDX Stock Holding History

Triumph Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.94K Hold
100
– – ﹤0.01% 1123
2025
Q4 		$12.2K Buy
+100
New +$12.5K ﹤0.01% 1016
2021
Q3 		– Sell
-20,051
Closed -$622K – 212
2021
Q2 		$622K Buy
+20,051
New +$556K 0.36% 70

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Triumph Capital Management's TMDX Position: Q1 2026 in Review

Triumph Capital Management held its Transmedics (TMDX) position steady in Q1 2026 at 100 shares worth $9.94K. The position accounts for ﹤0.01% of the portfolio, ranked #1123.

Triumph Capital Management first reported a position in TMDX in Q2 2021 and has held it in 3 quarters since. The position peaked at $622K in Q2 2021. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Triumph Capital Management held 100 shares of Transmedics worth $9.94K as of Q1 2026.
  • Triumph Capital Management left its Transmedics share count unchanged in Q1 2026.
  • Transmedics made up ﹤0.01% of Triumph Capital Management's portfolio in Q1 2026, its #1123 holding.
  • Triumph Capital Management first reported a position in Transmedics in Q2 2021 and has held it in 3 quarters since.
  • Triumph Capital Management's Transmedics position peaked at $622K in Q2 2021.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Triumph Capital Management's 13F filing for Q1 2026, filed 13 May 2026.